MAPK1 and neoplasm: HNRNPA2B1 contributes in activating cyclo-oxygenase 2, which eventually leads to tumor growth, promoting EMT through ERK/SNAIL signaling reduced cell proliferation and prolonged S-phase and suppressed subcutaneous tumorigenicity.